Sign in

CIK 0001635088

  • Large accelerated filer

Roivant Sciences Ltd.

Sign in to watch
Ticker
ROIV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
Bermuda
Entity type
Operating
EIN
981173944
Phone
+44 12955950
Business address
7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
  1. 4 Shares withheld for taxes Chief Accounting Officer gave up 1,508 shares (to pay taxes)
  2. 4 Shares withheld for taxes President & COO gave up 16,002 shares (to pay taxes)
  3. 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)
  4. 4 Planned sale President & COO sold 96,950 shares at $10.92 ($1,058,694)
  5. 4 Shares withheld for taxes CFO gave up 1,896 shares (to pay taxes)
  6. 4 Grant or award Director acquired 1,570 shares (grant or award)
  7. 4 Grant or award Director acquired 1,328 shares (grant or award)
  8. 4 Grant or award Director acquired 1,207 shares (grant or award)
  9. 4 Shares withheld for taxes Chief Accounting Officer gave up 1,506 shares (to pay taxes)
  10. 4 Grant or award Director acquired 3,366 shares (grant or award)
  11. 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)
  12. 4 Shares withheld for taxes President & COO gave up 12,377 shares (to pay taxes)
  13. 4 Open-market sale 10% owner sold 3,000,000 shares at $11.05 ($33,150,000)
  14. 4 Shares withheld for taxes 10% owner gave up 133,911 shares (to pay taxes)
  15. 4 Shares withheld for taxes CFO gave up 1,913 shares (to pay taxes)
  16. 4 Shares withheld for taxes CEO gave up 22,043 shares (to pay taxes)
  17. 4 Option exercise Pres&Chief Investment Officer acquired 71,365 shares (option exercise)
  18. 4 Shares withheld for taxes Chief Accounting Officer gave up 6 shares (to pay taxes)
  19. 4 Shares withheld for taxes President & COO gave up 16,003 shares (to pay taxes)
  20. 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)

Page 14 of 26 · 511 filings